Your browser doesn't support javascript.
loading
A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation.
Gassama, S; Garmendia, A; Lejeune, F X; Boudot de la Motte, M; Louapre, C; Papeix, C; Maillart, E; Roux, T.
Affiliation
  • Gassama S; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Garmendia A; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Lejeune FX; Paris-Brain Institute (ICM), Paris Brain Institute's Data and Analysis Core, Pitié-Salpêtrière Hospital, Sorbonne université, Inserm U1127, CNRS UMR 7225, Paris, France.
  • Boudot de la Motte M; Department of Neurology, Fondation Adolphe-de-Rothschild Hospital, Paris, France.
  • Louapre C; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Papeix C; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Maillart E; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France.
  • Roux T; Department of Neurology, centre de ressources et de compétences SEP - Paris, Pitié-Salpêtrière University Hospital, AP-HP, 47, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: thomas.roux@aphp.fr.
Rev Neurol (Paris) ; 179(9): 1035-1038, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37633735
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Rev Neurol (Paris) Year: 2023 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Rev Neurol (Paris) Year: 2023 Document type: Article Affiliation country: Francia